Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Oncogenic Signaling Pathways in The Cancer Genome Atlas.

Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M; Cancer Genome Atlas Research Network, Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N.

Cell. 2018 Apr 5;173(2):321-337.e10. doi: 10.1016/j.cell.2018.03.035.

2.

Salivary glands regenerate after radiation injury through SOX2-mediated secretory cell replacement.

Emmerson E, May AJ, Berthoin L, Cruz-Pacheco N, Nathan S, Mattingly AJ, Chang JL, Ryan WR, Tward AD, Knox SM.

EMBO Mol Med. 2018 Mar;10(3). pii: e8051. doi: 10.15252/emmm.201708051.

3.

Defining epithelial cell dynamics and lineage relationships in the developing lacrimal gland.

Farmer DT, Nathan S, Finley JK, Shengyang Yu K, Emmerson E, Byrnes LE, Sneddon JB, McManus MT, Tward AD, Knox SM.

Development. 2017 Jul 1;144(13):2517-2528. doi: 10.1242/dev.150789. Epub 2017 Jun 2.

4.
5.

Auditory brainstem implantation in a 16-month-old boy with cochlear hypoplasia.

Puram SV, Tward AD, Jung DH, Dilger AE, Herrmann BS, Duhaime AC, Barker FG 2nd, Lee DJ.

Otol Neurotol. 2015 Apr;36(4):618-24. doi: 10.1097/MAO.0000000000000676.

PMID:
25473959
6.

High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma.

Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW.

Cancer. 2013 Aug 15;119(16):3034-42. doi: 10.1002/cncr.28150. Epub 2013 May 20.

7.

The mutational landscape of head and neck squamous cell carcinoma.

Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortés ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis JR.

Science. 2011 Aug 26;333(6046):1157-60. doi: 10.1126/science.1208130. Epub 2011 Jul 28.

8.

Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer.

Lee SA, Ho C, Roy R, Kosinski C, Patil MA, Tward AD, Fridlyand J, Chen X.

Hepatology. 2008 Apr;47(4):1200-10. doi: 10.1002/hep.22169.

PMID:
18214995
9.

Distinct pathways of genomic progression to benign and malignant tumors of the liver.

Tward AD, Jones KD, Yant S, Cheung ST, Fan ST, Chen X, Kay MA, Wang R, Bishop JM.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14771-6. Epub 2007 Sep 4.

10.

Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC.

Goga A, Yang D, Tward AD, Morgan DO, Bishop JM.

Nat Med. 2007 Jul;13(7):820-7. Epub 2007 Jun 24.

PMID:
17589519
11.

Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.

Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE, Brown PO.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14842-7. Epub 2006 Sep 26.

12.

Genomic progression in mouse models for liver tumors.

Tward AD, Jones KD, Yant S, Kay MA, Wang R, Bishop JM.

Cold Spring Harb Symp Quant Biol. 2005;70:217-24.

PMID:
16869757
13.

Hepatocellular carcinoma in Txnip-deficient mice.

Sheth SS, Bodnar JS, Ghazalpour A, Thipphavong CK, Tsutsumi S, Tward AD, Demant P, Kodama T, Aburatani H, Lusis AJ.

Oncogene. 2006 Jun 15;25(25):3528-36. Epub 2006 Apr 10.

PMID:
16607285
14.

Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants.

Furlong CE, Cole TB, Jarvik GP, Pettan-Brewer C, Geiss GK, Richter RJ, Shih DM, Tward AD, Lusis AJ, Costa LG.

Neurotoxicology. 2005 Aug;26(4):651-9. Review.

PMID:
16112327
15.

Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism.

Cole TB, Walter BJ, Shih DM, Tward AD, Lusis AJ, Timchalk C, Richter RJ, Costa LG, Furlong CE.

Pharmacogenet Genomics. 2005 Aug;15(8):589-98.

PMID:
16007003
16.

Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse.

Araujo JA, Meng L, Tward AD, Hancock WW, Zhai Y, Lee A, Ishikawa K, Iyer S, Buelow R, Busuttil RW, Shih DM, Lusis AJ, Kupiec-Weglinski JW.

J Immunol. 2003 Aug 1;171(3):1572-80.

17.

MSJAMA. From grave robbing to gifting: cadaver supply in the United States.

Tward AD, Patterson HA.

JAMA. 2002 Mar 6;287(9):1183. No abstract available.

PMID:
11879122

Supplemental Content

Loading ...
Support Center